Artificial intelligence (AI) and big data in cancer and precision oncology.

AI, Artificial Intelligence Artificial intelligence Big datasets CNV, Copy Number Variations Deep learning Diagnosis Digital pathology FFPE, Formalin-Fixed Paraffin-Embedded LYNA, LYmph Node Assistant ML, Machine Learning Machine learning Medical imaging NGS and bioinformatics NGS, Next Generation Sequencing Precision oncology Prognosis and drug discovery TCGA, The Cancer Genome Atlas Treatment WSI, Whole Slide Imaging

Journal

Computational and structural biotechnology journal
ISSN: 2001-0370
Titre abrégé: Comput Struct Biotechnol J
Pays: Netherlands
ID NLM: 101585369

Informations de publication

Date de publication:
2020
Historique:
received: 03 07 2020
revised: 21 08 2020
accepted: 21 08 2020
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 1 10 2020
Statut: epublish

Résumé

Artificial intelligence (AI) and machine learning have significantly influenced many facets of the healthcare sector. Advancement in technology has paved the way for analysis of big datasets in a cost- and time-effective manner. Clinical oncology and research are reaping the benefits of AI. The burden of cancer is a global phenomenon. Efforts to reduce mortality rates requires early diagnosis for effective therapeutic interventions. However, metastatic and recurrent cancers evolve and acquire drug resistance. It is imperative to detect novel biomarkers that induce drug resistance and identify therapeutic targets to enhance treatment regimes. The introduction of the next generation sequencing (NGS) platforms address these demands, has revolutionised the future of precision oncology. NGS offers several clinical applications that are important for risk predictor, early detection of disease, diagnosis by sequencing and medical imaging, accurate prognosis, biomarker identification and identification of therapeutic targets for novel drug discovery. NGS generates large datasets that demand specialised bioinformatics resources to analyse the data that is relevant and clinically significant. Through these applications of AI, cancer diagnostics and prognostic prediction are enhanced with NGS and medical imaging that delivers high resolution images. Regardless of the improvements in technology, AI has some challenges and limitations, and the clinical application of NGS remains to be validated. By continuing to enhance the progression of innovation and technology, the future of AI and precision oncology show great promise.

Identifiants

pubmed: 32994889
doi: 10.1016/j.csbj.2020.08.019
pii: S2001-0370(20)30372-X
pmc: PMC7490765
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

2300-2311

Informations de copyright

© 2020 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Cancer Lett. 2018 Aug 1;428:104-116
pubmed: 29704517
Target Oncol. 2018 Aug;13(4):495-500
pubmed: 29974386
Eur Respir J. 2014 Jun;43(6):1776-86
pubmed: 24525445
Cell. 2018 Apr 5;173(2):400-416.e11
pubmed: 29625055
NPJ Digit Med. 2019 Jun 7;2:48
pubmed: 31304394
IEEE Rev Biomed Eng. 2016;9:234-63
pubmed: 26742143
Genome Med. 2020 Apr 21;12(1):35
pubmed: 32317009
Nat Rev Dis Primers. 2019 Sep 23;5(1):66
pubmed: 31548545
Artif Intell Med. 2019 Apr;95:82-87
pubmed: 30266546
J Clin Oncol. 2006 Nov 20;24(33):5313-27
pubmed: 17060676
Front Genet. 2018 Sep 05;9:366
pubmed: 30233647
J Pathol Inform. 2018 Nov 14;9:38
pubmed: 30607305
Br J Cancer. 2003 Dec;89 Suppl 3:S23-8
pubmed: 14661043
Front Oncol. 2020 Apr 09;10:447
pubmed: 32328458
Adv Mater. 2020 Apr;32(13):e1901989
pubmed: 31286573
Breast. 2020 Feb;49:267-273
pubmed: 31935669
Oncotarget. 2018 Apr 17;9(29):20761-20768
pubmed: 29755687
J Pathol Inform. 2014 Nov 28;5(1):43
pubmed: 25535591
JAMA. 2015 Sep 1;314(9):913-25
pubmed: 26325560
ESMO Open. 2019 Sep 18;4(5):e000525
pubmed: 31673425
Nature. 2017 Aug 17;548(7667):297-303
pubmed: 28783718
Int J Mol Sci. 2017 Feb 15;18(2):
pubmed: 28212287
Lancet Oncol. 2019 May;20(5):e253-e261
pubmed: 31044723
Stroke Vasc Neurol. 2017 Jun 21;2(4):230-243
pubmed: 29507784
Arch Pathol Lab Med. 2019 Feb;143(2):222-234
pubmed: 30307746
J Med Genet. 2019 Mar;56(3):186-194
pubmed: 30567904
Nature. 2017 Feb 2;542(7639):115-118
pubmed: 28117445
Sci Rep. 2013;3:1689
pubmed: 23604310
Wiley Interdiscip Rev RNA. 2019 May;10(3):e1527
pubmed: 30773852
PLoS One. 2019 Nov 25;14(11):e0224379
pubmed: 31765373
Arch Pathol Lab Med. 2018 Nov;142(11):1383-1387
pubmed: 29708429
J Med Internet Res. 2020 Feb 20;22(2):e14122
pubmed: 32130123
Eur Respir J. 2019 Apr 11;53(4):
pubmed: 30765505
Comput Struct Biotechnol J. 2019 Nov 07;17:1348-1359
pubmed: 31762958
Histopathology. 2019 Feb;74(3):372-376
pubmed: 30270453
Nat Med. 2020 Feb;26(2):188-192
pubmed: 32042193
BMC Med. 2019 Oct 29;17(1):195
pubmed: 31665002
Front Oncol. 2020 Apr 03;10:342
pubmed: 32309212
Front Med (Lausanne). 2019 Oct 01;6:185
pubmed: 31632973
JAMA Netw Open. 2019 Mar 1;2(3):e191095
pubmed: 30901052
Future Healthc J. 2019 Jun;6(2):94-98
pubmed: 31363513
Med Arch. 2017 Aug;71(4):288-292
pubmed: 28974852
Ann Oncol. 2018 Feb 1;29(2):418-423
pubmed: 29324970
Radiology. 2019 Feb;290(2):305-314
pubmed: 30457482
J Pathol. 2019 Nov;249(3):286-294
pubmed: 31355445
Nat Rev Clin Oncol. 2019 Nov;16(11):703-715
pubmed: 31399699
NPJ Breast Cancer. 2018 Dec 5;4:39
pubmed: 30534596
Nat Rev Genet. 2016 May 17;17(6):333-51
pubmed: 27184599
Mol Oncol. 2012 Apr;6(2):140-6
pubmed: 22356776
Biomed Pharmacother. 2020 Aug;128:110255
pubmed: 32446113
Artif Intell Med. 2016 Jul;71:57-61
pubmed: 27506131
Nat Clin Pract Oncol. 2008 Sep;5(9):531-42
pubmed: 18607391
Cell. 2018 Apr 5;173(2):283-285
pubmed: 29625045
Clin Cancer Res. 2017 Oct 15;23(20):6305-6314
pubmed: 28710315
Magn Reson Imaging. 2020 May;68:A1-A4
pubmed: 31857130
Diagn Pathol. 2019 Dec 27;14(1):138
pubmed: 31881972
Semin Cancer Biol. 2018 Oct;52(Pt 1):56-73
pubmed: 28882552
ScientificWorldJournal. 2019 Mar 20;2019:5198931
pubmed: 31015822
Br J Cancer. 2019 Jan;120(2):247-255
pubmed: 30563991
Biomed Res Int. 2015;2015:639021
pubmed: 26137488
BMC Cancer. 2015 Nov 17;15:912
pubmed: 26577449
Exp Mol Pathol. 2018 Jun;104(3):161-169
pubmed: 29608913
Oncotarget. 2018 Jan 10;9(10):9043-9060
pubmed: 29507673
Am J Surg Pathol. 2018 Jan;42(1):39-52
pubmed: 28961557
J Med Radiat Sci. 2019 Dec;66(4):292-295
pubmed: 31709775
Arch Pathol Lab Med. 2019 Jul;143(7):859-868
pubmed: 30295070
J Family Med Prim Care. 2019 Jul;8(7):2328-2331
pubmed: 31463251
Pathol Int. 2019 Jun;69(6):341-349
pubmed: 31295382
Clin Infect Dis. 2018 Jan 6;66(1):149-153
pubmed: 29020316
Biomed Res Int. 2019 Nov 11;2019:8427042
pubmed: 31886259
Hum Genet. 2019 Feb;138(2):109-124
pubmed: 30671672
BMC Genomics. 2012 Jul 24;13:341
pubmed: 22827831
Biochim Biophys Acta Rev Cancer. 2019 Dec;1872(2):188315
pubmed: 31647985
Sci Transl Med. 2011 Nov 9;3(108):108ra113
pubmed: 22072638
NPJ Digit Med. 2019 Jun 21;2:56
pubmed: 31304402
Front Oncol. 2019 Jun 07;9:482
pubmed: 31231613
Gynecol Oncol. 2019 Jan;152(1):194-201
pubmed: 30297273
Cancers (Basel). 2018 Nov 20;10(11):
pubmed: 30463359
Circ Cardiovasc Genet. 2013 Aug;6(4):427-34
pubmed: 23852418
Arch Pathol Lab Med. 2013 Apr;137(4):518-24
pubmed: 23323732
Cancers (Basel). 2019 Jan 20;11(1):
pubmed: 30669514
IEEE Trans Med Imaging. 2017 Jul;36(7):1550-1560
pubmed: 28287963
J Pathol Inform. 2019 Mar 08;10:9
pubmed: 30984469
Br J Haematol. 2017 Apr;177(2):283-286
pubmed: 28146330
Biomark Cancer. 2019 Jul 05;11:1179299X19860815
pubmed: 31308780
Ther Adv Med Oncol. 2014 Nov;6(6):293-304
pubmed: 25364394
Int J Comput Assist Radiol Surg. 2017 Aug;12(8):1293-1305
pubmed: 28634789
J Pathol Inform. 2015 Nov 27;6:63
pubmed: 26730353
Cancers (Basel). 2019 Aug 22;11(9):
pubmed: 31443496
Yonago Acta Med. 2013 Jun;56(2):43-50
pubmed: 24031151
PLoS One. 2017 Nov 9;12(11):e0185032
pubmed: 29121063
JAMA Netw Open. 2019 Oct 2;2(10):e1913968
pubmed: 31651965
Cancer Manag Res. 2020 Mar 16;12:1947-1958
pubmed: 32214852
Afr J Med Med Sci. 2009 Jun;38 Suppl 2:81-8
pubmed: 20229744
PLoS One. 2018 Apr 12;13(4):e0195621
pubmed: 29649302
Clin Biochem. 2004 Jul;37(7):584-94
pubmed: 15234240

Auteurs

Zodwa Dlamini (Z)

SAMRC/UP Precision Prevention & Novel Drug Targets for HIV-Associated Cancers (PPNDTHAC) Extramural Unit, Pan African Cancer Research Institute (PACRI), University of Pretoria, Faculty of Health Sciences, Hatfield 0028, South Africa.

Flavia Zita Francies (FZ)

SAMRC/UP Precision Prevention & Novel Drug Targets for HIV-Associated Cancers (PPNDTHAC) Extramural Unit, Pan African Cancer Research Institute (PACRI), University of Pretoria, Faculty of Health Sciences, Hatfield 0028, South Africa.

Rodney Hull (R)

SAMRC/UP Precision Prevention & Novel Drug Targets for HIV-Associated Cancers (PPNDTHAC) Extramural Unit, Pan African Cancer Research Institute (PACRI), University of Pretoria, Faculty of Health Sciences, Hatfield 0028, South Africa.

Rahaba Marima (R)

SAMRC/UP Precision Prevention & Novel Drug Targets for HIV-Associated Cancers (PPNDTHAC) Extramural Unit, Pan African Cancer Research Institute (PACRI), University of Pretoria, Faculty of Health Sciences, Hatfield 0028, South Africa.

Classifications MeSH